If you work in bowel cancer screening you may have recently read about a trial I led about treatment options for people at higher risk of bowel cancer. The name of the trial is certainly one you can't forget. We named it …
Mark Hull is a consultant gastroenterologist in Leeds. He is also a researcher at the University of Leeds looking into ways of better preventing bowel cancer whether that be through screening, use of medicines and nutritional products, or avoidance of excess body weight. He trained in Cambridge, Oxford and Nottingham. He likes running with his dog, skiing and going back over the Pennines to watch football in his home city of Manchester (of the blue variety).
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021